Announce Date | 04/22/2025 |
EPS Normalized Actual | $1.88 (Beat by $0.25) |
EPS GAAP Actual | $1.88 (Beat by $0.25) |
Revenue Actual | $5.741B |
Revenue Surprise | Beat by $5741M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 11.54 | 17.42 | 11.26534 | 12.03539 | 1 |
Dec 2028 | 11.895 | 16.9 | 11.63841 | 12.20828 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 1.33 | 1.33 | 5.741B | 39.26% | 5741M |
FQ4 2024 (Dec 2024) | 1.5 | 1.5 | 6.538B | 42.2% | 6538M |
FQ3 2024 (Sep 2024) | 1.13 | 1.13 | 3.401B | -102.09% | 3401M |
FQ2 2024 (Jun 2024) | 1.23 | 1.23 | 5.743B | 29.64% | 5743M |
FQ1 2024 (Mar 2024) | 1.47 | 1.47 | 3.487B | -105.53% | 3487M |
FQ4 2023 (Dec 2023) | 1.46 | 1.46 | 3.779B | -121.46% | 3779M |
FQ3 2023 (Sep 2023) | 1.53 | 1.53 | 6.873B | -12.77% | 6873M |
FQ2 2023 (Jun 2023) | 1.5 | 1.5 | 4.041B | 100% | 4041M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 2.78423 | -- | 2.75236 | 2.81282 | 8 |
FQ3 2027 (Sep 2027) | 2.08076 | -- | 2.05694 | 2.10213 | 11 |
FQ2 2027 (Jun 2027) | 2.12496 | -- | 2.10064 | 2.14678 | 8 |
FQ1 2027 (Mar 2027) | 1.93366 | -- | 1.91153 | 1.95352 | 8 |
FQ4 2026 (Dec 2026) | 2.8555 | -- | 2.78809 | 2.95341 | 6 |
FQ3 2026 (Sep 2026) | 2.06462 | -- | 2.01588 | 2.13541 | 4 |
FQ2 2026 (Jun 2026) | 1.956 | -- | 1.91305 | 2.01151 | 10 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 7.81B | -- | 7.75B | 7.88B | 12 |
FQ3 2027 (Sep 2027) | 6.77B | -- | 6.71B | 6.82B | 8 |
FQ2 2027 (Jun 2027) | 6.69B | -- | 6.63B | 6.75B | 8 |
FQ1 2027 (Mar 2027) | 6.49B | -- | 6.43B | 6.54B | 8 |
FQ4 2026 (Dec 2026) | 7.59B | -- | 7.46B | 7.79B | 6 |
FQ3 2026 (Sep 2026) | 6.49B | -- | 6.37B | 6.66B | 6 |
FQ2 2026 (Jun 2026) | 6.47B | -- | 6.36B | 6.61B | 11 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 1.33 | 1.33 | 100% | |
FQ4 2024 (Dec 2024) | 1.5 | 1.5 | 100% | |
FQ3 2024 (Sep 2024) | 1.13 | 1.13 | 100% | |
FQ2 2024 (Jun 2024) | 1.23 | 1.23 | 100% | |
FQ1 2024 (Mar 2024) | 1.47 | 1.47 | 100% | |
FQ4 2023 (Dec 2023) | 1.46 | 1.46 | 100% | |
FQ3 2023 (Sep 2023) | 1.53 | 1.53 | 100% | |
FQ2 2023 (Jun 2023) | 1.5 | 1.5 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $5.74B | $5741M | 100% |
FQ4 2024 (Dec 2024) | $0B | $6.54B | $6538M | 100% |
FQ3 2024 (Sep 2024) | $0B | $3.4B | $3401M | 100% |
FQ2 2024 (Jun 2024) | $0B | $5.74B | $5743M | 100% |
FQ1 2024 (Mar 2024) | $0B | $3.49B | $3487M | 100% |
FQ4 2023 (Dec 2023) | $0B | $3.78B | $3779M | 100% |
FQ3 2023 (Sep 2023) | $0B | $6.87B | $6873M | 100% |
FQ2 2023 (Jun 2023) | $0B | $4.04B | $4041M | 100% |